СУРУНКАЛИ БОШ ОҒРИҚНИ ДАВОЛАШНИ ОПТИМАЛЛАШТИРИЛГАН УСУЛИ
##article.subject##:
Сурункали бош оғриқ, мигрен, ВАШ, CPAQ-R, HADS, SF-36, когнитив терапия, ҳаёт сифати, психотерапия, фармакотерапия, когнитив функция##article.abstract##
Ушбу мақолада сурункали бош оғриқларни, жумладан, мигрен турларини самарали даволаш ва профилактика қилишнинг оптимал усуллари таҳлил қилинган. Тадқиқотда визуал аналог шкаласи (ВАШ), Migraine Disability Assessment Test (MIDAS), Headache Impact Test (HIT-6), Short Form Health Survey (SF-36), HADS ва CPAQ-R сингари стандартлаштирилган инструментлардан фойдаланилган. Натижалар даволаш жараёни оғриқ даражасини пасайтириши, руҳий барқарорликни тиклаши, ҳаёт сифатини яхшилаши ва когнитив функцияларни яхшилашига олиб келганини кўрсатди. Айниқса, когнитив-хулқий терапия, антидепрессантлар ва анксиолитиклар билан комплекс ёндашувнинг самарадорлиги қайд этилди. Тадқиқот сурункали бош оғриқларни комплекс, индивидуал ёндашув асосида даволаш зарурлигини кўрсатади.
Библиографические ссылки
Bigal M.E., Liberman J.N., Lipton R.B. "Age-dependent prevalence and clinical features of migraine" // Neurology. 2006. Vol. 67, No.
P. 246–251.
Kosinski M., Bayliss M.S., Bjorner J.B., Ware J.E. Jr., Garber W.H., Batenhorst A., Cady R., Dahlöf C.G., Dowson A., Tepper S. "A six- item short-form survey for measuring headache impact: the HIT-6" // Quality of Life Research. 2003. Vol. 12, No. 8. P. 963–974. Ware J.E. Jr., Sherbourne C.D. "The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection" // Medical Care. 1992. Vol. 30, No. 6. P. 473–483.
Lantéri-Minet M., Duru G., Mudge M., Cottrell S. "Quality of life impairment, disability and economic burden associated with chronic migraine in France: a national survey" // Headache. 2011. Vol. 51, No. 5. P. 691–700.
Leonardi M., Raggi A. "Burden of migraine: international perspectives" // Neurological Sciences. 2013. Vol. 34, Suppl. 1. P. S117–S118.
Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M. "Prevalence and burden of migraine in the United States: data from the American Migraine Study II" // Headache. 2001. Vol. 41, No. 7. P. 646–657.
Stewart W.F., Lipton R.B., Kolodner K., Sawyer J., Lee C., Liberman J.N. "Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers" // Pain. 2000. Vol. 88, No. 1. P. 41–52. ScienceDirect+1PubMed+1
Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., et al. "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" // The Lancet. 2012. Vol. 380, No. 9859. P. 2163–2196.
Wang S.J., Fuh J.L., Lu S.R., Juang K.D., Wang P.H. "Quality of life differs among headache diagnoses: analysis of SF-36 in a headache clinic" // Headache. 2001. Vol. 41, No. 1. P. 26–32. Buse D.C., Manack A.N., Fanning K.M., Serrano D., Reed M.L., Turkel C.C., Lipton R.B. "Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study" // Headache. 2012. Vol. 52, No. 10. P. 1456–1470.
Khaydarova Dildora Kadirovna, Khodjyeva Dilbar Tadjiyevna, Bobokulov Gulmurod Dilmurodovich. Optimization Of Neuroprotective Therapy Of Ischemic Stroke In The Acute Period. European Journal of Molecular & Clinical Medicine. Volume 07, Issue 03, 2020. Р. 3720-3723
Khodjieva D. T., Khaydarova D. K., Khaydarov N. K. Magnetic Resonance Imaging of Cerebral Hemorrhagic Stroke. International Journal of Psychosocial Rehabilitation, Vol. 24, 2020. Р 434-438.
Khaydarova D.K., Mansurova N.A. Analysis of Motor Complications in Parkinson’s Disease Phenotypes. Journal of Advances in Medicine and Medical Research. 25(5): 1-7, 2018;
